Therapeutic Options for NTRK-Mutated Thyroid Cancer

home / case-based-roundtable-series / therapeutic-options-for-ntrk-mutated-thyroid-cancer

This roundtable series evaluates genomic testing and NTRK-targeted treatment in patients with thyroid cancer as discussed by participants at virtual live events.

Larotrectinib Shows High Efficacy in Differentiated Thyroid Cancer

Larotrectinib Shows High Efficacy in Differentiated Thyroid Cancer

Lori J. Wirth, MD
December 20th 2021

Lori Wirth, MD, discusses the subanalysis of patients with thyroid cancer with NTRK fusion mutations in clinical trials for larotrectinib.

Sequencing Treatments for NTRK-Positive Thyroid Cancer

Sequencing Treatments for NTRK-Positive Thyroid Cancer

Krzysztof J. Misiukiewicz, MD
January 4th 2022

Krzysztof J. Misiukiewicz, MD, discusses sequencing of treatments in patients with NTRK-positive thyroid cancer.